WELCOME TO The government REPORT
Monroe-Union County EDC
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Huawei | January 27, 2020
The U.S. Commerce Department has withdrawn a controversial rule designed to reduce sales to China's Huawei Technologies. The Commerce Department in May placed Huawei on a trade blacklist, citing national security concerns. That allowed the U.S. government to restrict sales of American made goods to the company and a small number of items made abroad that contain U.S. technology. That ruling now appears to have been reversed. President Donald Trump's administration plans a cabinet-level m...
Appian | December 09, 2020
Appian (NASDAQ: APPN) today reported a joint effort with Accenture Federal Services (AFS), an auxiliary of Accenture (NYSE: ACN), to additionally disentangle the federal acquisition measure through low-code robotization. Through the joint exertion, AFS is growing new delivery accelerators to upgrade Appian's Acquisition Solutions, which streamline the acquisition cycle and approve that the cycle completely follows the Federal Acquisition Regulations for defense and regular citizen organizati...
Arthur | February 19, 2022
The Joint Artificial Intelligence Center (JAIC) has selected Arthur to deliver its industry-leading AI performance management solution as part of the Test and Evaluation (T&E) Blanket Purchase Agreement (BPA,) a $249M effort to accelerate production AI capabilities across the Department of Defense (DoD).
This new vehicle will allow the DOD to leverage the Arthur platform for AI monitoring and optimization to deliver better results with accuracy, explainability, and fairness. A...
CNBC | March 19, 2020
When Dr. Mike Pellini, a physician and biotech investor, read the news about the spread of a virus that caused pneumonia-like symptoms, he decided to keep on hand a supply of an anti-malarial drug called chloroquine. Pellini, who tweeted about the decision to his followers in early February, was early to this thinking. A month later, Tesla CEO Elon Musk sparked massive interest in the drug after tweeting that chloroquine was “maybe worth considering” as a potential treatment for the ...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE